![](/img/cover-not-exists.png)
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung
Baird, Kristin, Glod, John, Steinberg, Seth M., Reinke, Denise, Pressey, Joseph G., Mascarenhas, Leo, Federman, Noah, Marina, Neyssa, Chawla, Sant, Lagmay, Joanne P., Goldberg, John, Milhem, Mohammed,Volume:
2020
Journal:
Sarcoma
DOI:
10.1155/2020/7935475
Date:
May, 2020
File:
PDF, 1.33 MB
2020